tradingkey.logo

Amneal Pharmaceuticals Inc

AMRX
查看详细走势图
12.900USD
+0.030+0.23%
交易中 美东报价延迟15分钟
4.05B总市值
723.91市盈率 TTM

Amneal Pharmaceuticals Inc

12.900
+0.030+0.23%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.23%

5天

+2.06%

1月

+3.70%

6月

+60.25%

今年开始到现在

+62.88%

1年

+64.33%

查看详细走势图

TradingKey Amneal Pharmaceuticals Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Amneal Pharmaceuticals Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在药品行业排名20/158位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价13.75。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Amneal Pharmaceuticals Inc评分

相关信息

行业排名
20 / 158
全市场排名
57 / 4562
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 5 位分析师
买入
评级
13.750
目标均价
+15.84%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Amneal Pharmaceuticals Inc亮点

亮点风险
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
业绩高增长
公司营业收入稳步增长,连续3年增长26.29%
估值高估
公司最新PE估值722.22,处于3年历史高位
机构加仓
最新机构持股154.72M股,环比增加0.04%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值17.90M

Amneal Pharmaceuticals Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Amneal Pharmaceuticals Inc简介

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
公司代码AMRX
公司Amneal Pharmaceuticals Inc
CEOPatel (Chintu)
网址https://amneal.com/

常见问题

Amneal Pharmaceuticals Inc(AMRX)的当前股价是多少?

Amneal Pharmaceuticals Inc(AMRX)的当前股价是 12.900。

Amneal Pharmaceuticals Inc的股票代码是什么?

Amneal Pharmaceuticals Inc的股票代码是AMRX。

Amneal Pharmaceuticals Inc股票的52周最高点是多少?

Amneal Pharmaceuticals Inc股票的52周最高点是12.975。

Amneal Pharmaceuticals Inc股票的52周最低点是多少?

Amneal Pharmaceuticals Inc股票的52周最低点是6.685。

Amneal Pharmaceuticals Inc的市值是多少?

Amneal Pharmaceuticals Inc的市值是4.05B。

Amneal Pharmaceuticals Inc的净利润是多少?

Amneal Pharmaceuticals Inc的净利润为-116.89M。

现在Amneal Pharmaceuticals Inc(AMRX)的股票是买入、持有还是卖出?

根据分析师评级,Amneal Pharmaceuticals Inc(AMRX)的总体评级为买入,目标价格为13.750。

Amneal Pharmaceuticals Inc(AMRX)股票的每股收益(EPS TTM)是多少

Amneal Pharmaceuticals Inc(AMRX)股票的每股收益(EPS TTM)是0.018。
KeyAI